42-kDa 片段 (MSP142)(细胞库），NR-1_Vaccinia virus

MRA-477?? Hybridoma S1-1G3 Anti-Plasmodium falciparum Merozoite Surface Protein 1, 42-kDa Fragment (MSP142)(Cell Banks)|Plasmodium falciparum|Hybridoma S1-1G3 Anti-Plasmodium falciparum Merozoite Surface Protein 1, 42-kDa Fragment (MSP142)|-100°C or colder|CA LongAcknowledgment for publications should read "The following reagent was obtained through BEI Resources, NIAID, NIH: Hybridoma S1-1G3 Anti-Plasmodium falciparum Merozoite Surface Protein 1, 42-kDa Fragment (MSP1₄₂), MRA-477, contributed by Carole A. Long."|Quantity limit per order for this item is 1. This item can be ordered twice a year. Orders over this limit will be sent to NIAID for approval before shipment. The murine hybridoma cell line, S1-1G3, was generated by the fusion of mouse myeloma cells with splenocytes from female BALB/c mice immunized with the 42-kDa fragment of the merozoite surface protein 1 (MSP1₄₂) of Plasmodium falciparum (P. falciparum), strain FVO. The monoclonal antibody produced, anti-MSP1₄₂, is specific for the 33-kDa region of the MSP1 (MSP1₃₃) of P. falciparum, strain FVO. Each vial contains approximately 0.5 mL of hybridoma cells in cell culture medium supplemented with 10% dimethylsulfoxide (DMSO) at a concentration of 5 × 10⁶ cells per mL. Sufficient cells are provided to initiate at least one new culture. Hybridoma S1-1G3 produces monoclonal antibody of the IgG1 subclass, which specifically recognizes MSP1₃₃ of P. falciparum, strain FVO, and is not growth inhibitory on Plasmodium falciparum parasites.

MRA-475?? Hybridoma S1-1D7 Anti-Plasmodium falciparum Merozoite Surface Protein 1, 42-kDa Fragment (MSP142)(Cell Banks)|Plasmodium falciparum|Hybridoma S1-1D7 Anti-Plasmodium falciparum Merozoite Surface Protein 1, 42-kDa Fragment (MSP142)|-100°C or colder, preferably in the vapor phase of a liquid nitrogen freezer|CA LongAcknowledgment for publications should read “The following reagent was obtained through BEI Resources, NIAID, NIH: Hybridoma S1-1D7 Anti-Plasmodium falciparum Merozoite Surface Protein 1, 42 kDa Fragment (MSP142), MRA-475, contributed by Carole A. Long.”|

Quantity limit per order for this item is 1. This item can be ordered twice a year. Orders over this limit will be sent to NIAID for approval before shipment. 

The murine hybridoma cell line, S1-1D7, was generated by the fusion of mouse myeloma cells with splenocytes from female BALB/c mice immunized with the 42-kDa fragment of the merozoite surface protein 1 (MSP1₄₂) of Plasmodium falciparum (P. falciparum), strain FVO. The monoclonal antibody produced, anti-MSP1₄₂, is specific for the 33-kDa region of the MSP1 (MSP1₃₃) of P. falciparum, strain FVO.

Each vial contains approximately 0.5 mL of hybridoma cells in cell culture medium supplemented with 10% dimethylsulfoxide (DMSO) at a concentration of 5 × 10⁶ cells per mL. Sufficient cells are provided to initiate at least one new culture.

Hybridoma S1-1D7 produces monoclonal antibody of the IgG2a subclass, which specifically recognizes MSP1₃₃ of P. falciparum, strain FVO, and is not growth inhibitory on P. falciparum parasites.

MRA-474?? Hybridoma S1-4A4 Anti-Plasmodium falciparum Merozoite Surface Protein 1, 42-kDa Fragment (MSP142)(Cell Banks)|Plasmodium falciparum|Hybridoma S1-4A4 Anti-Plasmodium falciparum Merozoite Surface Protein 1, 42-kDa Fragment (MSP142)|-100°C or colder, preferably in the vapor phase of a liquid nitrogen freezer|CA LongAcknowledgment for publications should read “The following reagent was obtained through BEI Resources, NIAID, NIH: Hybridoma S1-4A4 Anti-Plasmodium falciparum Merozoite Surface Protein 1, 42 kDa Fragment (MSP142), MRA-474, contributed by Carole A. Long.”|

Quantity limit per order for this item is 1. This item can be ordered twice a year. Orders over this limit will be sent to NIAID for approval before shipment. 

The murine hybridoma cell line, S1-4A4, was generated by the fusion of mouse myeloma cells with splenocytes from female BALB/c mice immunized with the 42-kDa fragment of the merozoite surface protein 1 (MSP1₄₂) of Plasmodium falciparum (P. falciparum), strain FVO. The monoclonal antibody produced, anti-MSP1₄₂, is specific for the C-terminal 19-kDa region of the MSP1 (MSP1₁₉) of P. falciparum, strain FVO.

Each vial contains approximately 0.5 mL of hybridoma cells in cell culture medium supplemented with 10% dimethylsulfoxide (DMSO) at a concentration of 5 × 10⁶ cells per mL. Sufficient cells are provided to initiate at least one new culture.

Hybridoma S1-4A4 produces antibody which specifically recognizes MSP1₁₉ of P. falciparum, strain FVO, and is not growth inhibitory on P. falciparum parasites.